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Abstract
Background: Understanding of nonalcoholic steatohepatitis (NASH) is hampered by the lack of a
suitable model. Our aim was to investigate whether long term high saturated-fat feeding would
induce NASH in rats.
Methods: 21 day-old rats fed high fat diets for 14 weeks, with either coconut oil or butter, and
were compared with rats feeding a standard diet or a methionine choline-deficient (MCD) diet, a
non physiological model of NASH.
Results: MCDD fed rats rapidly lost weight and showed NASH features. Rats fed coconut (86%
of saturated fatty acid) or butter (51% of saturated fatty acid) had an increased caloric intake
(+143% and +30%). At the end of the study period, total lipid ingestion in term of percentage of
energy intake was higher in both coconut (45%) and butter (42%) groups than in the standard (7%)
diet group. No change in body mass was observed as compared with standard rats at the end of
the experiment. However, high fat fed rats were fattier with enlarged white and brown adipose
tissue (BAT) depots, but they showed no liver steatosis and no difference in triglyceride content in
hepatocytes, as compared with standard rats. Absence of hepatic lipid accumulation with high fat
diets was not related to a higher lipid oxidation by isolated hepatocytes (unchanged ketogenesis
and oxygen consumption) or hepatic mitochondrial respiration but was rather associated with a
rise in BAT uncoupling protein UCP1 (+25–28% vs standard).
Conclusion: Long term high saturated fat feeding led to increased "peripheral" fat storage and
BAT thermogenesis but did not induce hepatic steatosis and NASH.
Published: 21 February 2007
Nutrition & Metabolism 2007, 4:4 doi:10.1186/1743-7075-4-4
Received: 6 September 2006
Accepted: 21 February 2007
This article is available from: http://www.nutritionandmetabolism.com/content/4/1/4
© 2007 Romestaing et al; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.Nutrition & Metabolism 2007, 4:4 http://www.nutritionandmetabolism.com/content/4/1/4
Page 2 of 14
(page number not for citation purposes)
Background
Non-alcoholic fatty liver diseases (NAFLD) are character-
ized by triglyceride accumulation in hepatocytes (i.e., liver
steatosis). In some cases, steatosis becomes complicated
by inflammation and can evolve to apoptosis, necrosis
and fibrosis. This association of steatosis to other lesions
is called non-alcoholic steatohepatitis or NASH [1], and
may evolve into cirrhosis and hepatocellular carcinoma.
NASH is a disease of emerging importance and is now
considered as the most common cause of chronic liver dis-
ease in the USA [2,3]. While the pathogenesis of NASH is
poorly understood, the hypothesis of two "hits" is recog-
nized [4]. Fat accumulation in the liver represents the
"first hit". The factor responsible for the second "hit" is
hepatic oxidative stress due to ROS emission and/or
increased cytokine release, enhancing lipid peroxidation,
mitochondrial DNA and respiratory chain damages [5,6].
Currently, no defined therapy is known to alter the course
of NASH [5,7-10].
The study of the pathogenic factor involved in NASH is
difficult because of the lack of a suitable experimental ani-
mal model [11]. Currently, available animal models are
rodents either with a genetic defect (ob/ob mice or Fa/Fa
rat) [12] or fed a methionine and choline deficient diet
(MCD diet) [13]. The latter model is commonly used but
induces a nutritional deficiency that is not observed in
patients with NASH. The major disadvantage of these
models is that they fail to reflect the multi-factorial fea-
tures of NASH observed in patients. High caloric intake
and obesity are factors frequently associated with NASH
in humans. In rodents, however, the situation is less clear
as rats fed high fat diets were shown to develop hepatic
steatosis in some studies [14-16] but not in others
[17,18]. Comparisons of the protocols used showed that
the composition and the palatability of the diets may play
an important role in the development of the obesity and
NASH. To overcome these difficulties, some authors gave
diet ad libitum while others strictly controlled the caloric
intake through intragastric diet infusion or force-feeding.
Lieber et al. used a liquid high fat diet given ad libitum to
rats [19] whereas Zou et al. controlled daily fat intake by
force-feeding rats [20]. In these two cases, high fat diet
induced mild steatosis (two fold increase in hepatic tria-
cylglycerol compared to control) and huge hepatic
inflammation. The main fat component of these two diets
was corn oil, (consisted of 13% (w/w) saturated fatty acid
(SFA), 24% monounsaturated fatty acid (MUFA) and 59%
polyunsaturated fatty acid (PUFA)). These PUFA were
almost entirely composed by pro-inflammatory n-6 poly-
unsaturated fatty acids which are known to be involved in
liver oxidative stress [21]. These models do not really
mimic human NASH diet features since a study reported
that patients with NASH usually have a diet with higher
levels of SFA (13.7% instead of 10.0% total kcal) and cho-
lesterol, and low levels of PUFA (3.5% (w/w) [22].
Consequently, to analyse NASH pathogenesis, the aims of
the present study were (i) to study the development of
steatosis following a SFA-rich diet, ii) to study the possible
evolution from steatosis to NASH and iii) to determine
the possible liver adaptations to this new condition. We
tested two high saturated fat diets with either coconut oil,
which contains roughly 86% SFA, or butter, which con-
tains 51% SFA. These diets were compared with the MCD
diet, the most common diet used to mimic NASH in
rodents.
Methods
Animals and diets
Our study was performed following the recommenda-
tions provided by the European Convention for the pro-
tection of Vertebrate Animals used for Experimental and
Scientific purposes (Council of Europe N° 123, Stras-
bourg, 1985). Male Wistar rats, purchased from Charles
River Laboratories France, were housed four per box on a
12-h light/dark cycle. Animals were allowed to acclimatise
to their new conditions for a week before the study. At the
age of 21 days the animals were allocated to four different
groups. The first group received a standard diet (A04 – Sci-
entific Animal Food & Engineering, France) (std, n = 10).
The second group had the choice between standard diet
and coconut diet (coco, n = 10), for 14 weeks. The third
group had the choice between standard diet and butter
diet (butter, n = 4) for 14 weeks as well. The methionine
and choline deficient diet (MCDD n = 10; ICN Pharma-
ceuticals France SA, ref n° 960439), was given for 6 weeks
from the age of 9 weeks. Diets components are shown in
Table 1. The coconut or butter diets had 67% of energy
derived from fat compared with the standard diet (7%).
High fat diets were weekly prepared in our laboratory in
pellets and stored at +4°C. The food was renewed every
day during the treatment and the standard and high fat
diet intakes are monitored daily independently. Rats had
free access to food and water and were weighed every week
for the duration of the study.
Histological study
Histological analyses were achieved in the gastroenterol-
ogy service of Caen hospital (France). Liver specimens
were fixed in 4% buffered formalin for 24 to 48 h. They
were then embedded in paraffin, cut at 5 μm, and rou-
tinely stained with hematoxylin-eosin (H&E) and reticu-
lin. Severity of steatosis was evaluatedusing the percentage
of macrovesicular fat within hepatocytes: mild (5 to 30
%); moderate (30 to 60 %); severe (more than 60%) [23].Nutrition & Metabolism 2007, 4:4 http://www.nutritionandmetabolism.com/content/4/1/4
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Mitochondrial preparation and utilisation
The liver was rapidly removed and finely minced and
washed with ice-cold isolation medium containing 250
mM sucrose, 2 mM KH2PO4, 1 mM EGTA and 20 mM
Tris-HCl (pH 7.2). Liver mitochondria were prepared by
standard differential centrifugation procedures [24].
Mitochondrial protein content was determined by the
Biuret method [25] with serum albumin as standard. For
the determination of oxygen consumption, mitochondria
were incubated at a concentration of 2 mg/mL in an oxy-
graph vessel with a Clark electrode, thermostatically con-
trolled at 37°C, in a medium containing 125 mM KCl, 1
mM EGTA, 2 mM KH2PO4, 20 mM Tris-HCl with 0.1%
fatty acid-free Bovin Serum Albumin (pH 7.2). The con-
trol state of respiration was initiated by the addition of 5
mM succinate/0.5 mM malate, in the presence of roten-
one (1.25 μM) while the addition of 1 mM ADP initiated
the active state of respiration (state 3). Oligomycin (1.25
μg/mg protein) was then added to the mitochondrial sus-
pension to determine the non-phosphorylating respira-
tory rate (state 4).
Hepatocyte isolation and closed vials incubation
Hepatocytes were isolated from 20–24 h starved rats as
previously described by Berry and Friend (Berry, 1969)
and modified by Groen et al. [26], by a two-step in situ
collagenase perfusion technique. Hepatocytes (10 mg/mL
dry weight) were incubated at 37°C in closed vials con-
taining a Krebs-bicarbonate buffer (120 mM NaCl, 4.8
mM KCl, 1.2 mM KH2PO4, 1.2 mM MgSO4, 24 mM
NaHCO3, pH 7.4) saturated with 95% O2/5% CO2 con-
taining BSA (2%, w/v) and 2.4 mM CaCl2. Experiments
were performed with 20 mM dihydroxyacetone, with or
without fatty acids, 4 mM octanoate or 2 mM oleate. After
20 min, oxygen uptake (JO2) was measured polarograph-
ically at 37°C with a Clark electrode before and after the
addition of 6 μg/ml oligomycin. At t = 0 and 30 min, sam-
ples of hepatocyte suspension were taken, quenched in
HClO4 (4% v/v final concentration) and neutralized with
2 M KOH/0.3 M MOPS for later enzymatic measure of 3-
hydroxybutyrate, acetoacetate and glucose as described by
Bergmeyer [27].
Adipocyte isolation
Adipocytes were prepared from retroperitoneal white fat
pads. 1.5 g of fat tissue was digested for 30 min at 37°C
with 2 mg/mL of type II collagenase. The digestion
medium was a Krebs-Ringer medium (139 mM NaCl, 5.4
mM KCl, 1 mM NaH2PO4, 1 mM MgSO4, 2.2 mM CaCl2,
pH 7.4) buffered with 20 mM Hepes, containing 2% (w/
v) BSA with 7 mM glucose. Isolated cells were obtained by
filtration through a coarse nylon mesh (250 μm) before
being washed twice with a 2% BSA buffer. Adipocytes
were then observed under a microscope and the determi-
nation of the diameter was measured on pictures of
roughly 200–250 cells using a calibrated scale.
Biochemical analyses
Liver triacylglycerol concentration was estimated from
glycerol release after ethanolic KOH hydrolysis [28], using
a commercial colorimetric kit (Biomerieux, France).
Western blot analysis
Mitochondria from brown adipose tissue (BAT) were pre-
pared as described previously. 40 μg of BAT mitochon-
drial proteins were separated by SDS-PAGE (12.8%
acrylamide) and transferred to polyvinylidene fluoride
membranes (Immobilon-P, Millipore). Immunological
detection was performed using a rabbit antiserum against
UCP1 (α-diagnostics UCP11-S (1:15000), USA). The
detection was realized with a horseradish peroxidase-cou-
pled anti-rabbit (Bio-Rad 170–6516 (1:5000)) secondary
Table 1: Components (g/kg) of the standard, coconut, butter and methionine-choline deficient (MCD) diets and their fatty acid (FA) 
composition.
standard diet coconut diet butter diet MCD diet
protein 160 170 170 175*
fat 27 460 460 100
cholesterol - - 0.9 -
saturated FA 3 398 236 15
monounsaturated FA 8 27 97 30
polyunsaturated FA 14.5 8 14 55
ω6 14.5 8 12 54
ω3t r a c e s - 2 1
carbohydrate 596 250 250 655
cellulose 44 20 20 30
m i n e r a l 5 05 05 04 0
moisture 123 50 50
(*: expressed as amino acids)Nutrition & Metabolism 2007, 4:4 http://www.nutritionandmetabolism.com/content/4/1/4
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antibody and an enhanced chemiluminescence (ECL)
detection kit (Amersham, UK). Quantification of autora-
diographs was performed by scanning densitometry.
Enzyme assays
BAT samples (40–50 mg) were immediately homoge-
nized at +4°C in 0.3 M phosphate buffer containing
0.05% bovine serum albumin (pH 7.7) using a glass Pot-
ter-Elvehjem homogenizer. Then, they were frozen at -
80°C and thawed three times to disrupt the mitochon-
drial membrane. 3-hydroxyacyl-CoA dehydrogenase
(HAD, EC 1.1.1.35) was spectrophotometrically deter-
mined as previously described by Lowry & Passonneau
[29]. Enzyme activity was determined at 25°C and
expressed as micromoles of substrate per minute per mil-
ligram of protein.
Statistical analysis
Differences between groups were determined using non-
parametric Mann & Whitney tests. Data were expressed as
mean values ± SEM and differences between means were
considered significant when P < 0.05.
Results
Caloric intake, body and tissue mass
The rats received either a standard diet with 7% of energy
derived from fat, or had free choice between the standard
diet and high fat diets with 67% of energy derived from
fat. The first high fat diet contained coconut oil, com-
posed of 86% of saturated fatty acid and especially lauric
acid (C12:0). The second high fat diet was realised with
milk butter that contains 51% of SFA, the most abundant
being palmitic acid (C16:0). The respective composition
of the two diets in the main fatty acids is presented in
Table 2. Because the rats had free access to either standard
(2900 kcal/kg) or high fat diets (5500 kcal/kg) we first
estimated total calorie ingestion per day and monitored
resulting body mass. Animals were housed four per cage.
Rats could freely choose between the standard and the
high fat diet which were both available within the cages.
The amount of food consumed per day from each respec-
tive diet was calculated and then that amount was divided
by four to estimate the consumption of each rat. As shown
in Fig. 1A, the total caloric intake was higher in both
groups fed with high fat diets than in rats fed the standard
diet. These caloric intakes at the end of the experiment
were 143% higher for coconut group (178 kcal/day/rat)
and 30% higher for butter group (95 kcal/day/rat), as
compared with standard group (73 kcal/day/rat). The pro-
file of lipids, proteins and carbohydrates ingestion at
weeks 3 and 16 of experiment is reported in Table 3 for
each group. The proportion of energy derived from lipids
was increased 1.5 fold for the coconut group to reach 45%
by the end of the protocol, while it reached 42% at week
16 of diet in the butter group. At the end of the study
period, total lipid ingestion, expressed as a percentage of
the calories ingested, was higher in both high fat diet
groups than in the standard diet (coconut 45% vs butter
42% vs standard 7% kcal total). In the coconut group, this
energy came mostly from SFA (41.3%) whereas in the but-
ter group energy was shared between SFA and MUFA
(28% and 12% respectively) (Table 3). Surprisingly, in
spite of a larger energy intake, body mass was not affected
in rats fed the high fat diets (Fig. 1B). However, fat mass
was largely affected. Hence, retroperitoneal white adipose
tissue depot (Fig. 2) was heavier in high fat diet rats
(+62% in coconut and +93% in butter) than in standard
rats. To investigate which factors were implicated in this
fat modification, adipocytes were isolated from retroperi-
toneal white adipose tissue, from coconut and standard
groups and their size and volume measured. A two-fold
increase in cell volume was observed with the coconut
diet, demonstrating that the change in white adipose tis-
sue mass was partly due to a change in the volume of indi-
vidual adipocytes (Fig. 3). Hence, the high fat diet groups
displayed the expected feature related to high lipid inges-
tion, i.e. retroperitoneal fat accumulation and adipocyte
growth.
An opposite picture was observed with MCD diet. Rats fed
a MCD diet showed a smaller food intake (Fig. 1C) and a
drop in body mass (Fig. 1D) as classically observed with
this diet [30-32]. The mass of retroperitoneal white adi-
pose tissue was dramatically reduced (-44%) in MCD rats
(Fig. 2) which clearly indicates no fat accumulation in
white adipose tissue. Conversely, the liver mass of MCD
rat was higher than that of controls (4.5 ± 0.2 vs 3.4 ± 0.1
g/100g; P < 0.05).
Liver histology and lipid content
Liver histology (Fig. 4A) from rats fed a standard diet
showed no steatosis, inflammatory cells or fibrosis. The
Table 2: Percentage of the main fatty acid (FA) measured in the 
coconut oil and butter.
% Coconut oil butter
Saturated FA 86.5 51.3
10:0 6 2.5
12:0 44.6 2.5
14:0 16.8 7.4
16:0 8.2 21.7
18:0 2.8 10
Monounsaturated FA 5.8 21
18:1 5.8 20
Polyunsaturated FA 1.8 3
18:2 1.8 2.7
18:3 0 0.3
Cholesterol 0 0.2
Oil composition was extracted from the USDA National Nutrient 
Database for Standard Reference. Values are in g/100 g.Nutrition & Metabolism 2007, 4:4 http://www.nutritionandmetabolism.com/content/4/1/4
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rats which were fed coconut oil or butter display a very
mild macrovacuolar steatosis (affecting less than 5% of
hepatocytes), whereas steatosis was severe (affecting more
than 60% of hepatocytes) in the MCDD rats and associ-
ated to inflammation. This massive steatosis in the
MCDD group was confirmed by triacylglycerol content,
which was 22-fold higher in MCDD rats than in controls.
High fat diet did not significantly increase liver triacylglyc-
erol content (Fig. 4B). Thus, MCDD rats demonstrated the
typical liver feature of non alcoholic steatohepatitis (stea-
tosis and inflammation), whereas both high fat diets
(coconut oil or butter) induced only very mild steatosis.
Ability of the liver to oxidize fatty acids
In order to understand why rats fed a high fat diet did not
develop liver injury, we searched for an increased capacity
for fatty acid oxidation in liver cells. Fatty acid oxidation
takes place in mitochondria and can be either partial,
leading to ketone body synthesis (3-hydroxybutyrate and
acetoacetate), or complete, leading to a large supply of
reducing equivalents to the oxidative phosphorylation,
thus resulting in a higher oxygen consumption. Fatty acid
oxidation was therefore assessed by the measurement of
both ketone body formation and hepatocyte respiration.
We used either a long chain fatty acid (oleate), which is
oxidized after transfer into the mitochondria by the carni-
tine-palmitoyl transferase (CPT), or a medium chain fatty
acid (octanoate), that enters the mitochondria without
any transporters. As expected, ketone body synthesis was
higher with octanoate than with oleate, due to the direct
entry of this fatty acid into the mitochondria. There was
no significant change in ketone body formation in
response to high fat diets, whatever the fatty acid used as
substrate (Fig. 5A). This was corroborated by similar res-
piratory rate of hepatocytes from the three group studied
(Fig. 5B).
Changes in dietary lipid can modify cell membrane com-
position that can, in turns, alter cell integrity resulting in
a metabolism decrease. Hence, we studied gluconeogene-
sis which is controlled by, and therefore reflects, hepato-
cyte energy state. Using dihydroxyacetone as substrate,
glucose production from isolated hepatocytes was not dif-
ferent in high fat diet groups as compared with standard
group (Fig. 5C).
To verify that whole cell respiration measurement was not
biased by the oxygen consumption of other organelles
such as peroxisomes, the respiration capacities of isolated
liver mitochondria were measured. Bovine serum albu-
min was added to eliminate any artefactual uncoupling
effect of free fatty acids. No difference was found between
mitochondrial oxygen consumption from high fat and
standard diet fed rats (Fig. 5D). Therefore, resistance to
steatosis was not explained by an enhanced ability of the
liver to oxidize fatty acids.
Brown adipose tissue, fatty acid oxidation and uncoupling 
protein 1
Despite enhanced lipid ingestion in the high fat diet ani-
mals, their body mass did not increase and fatty acids
were not stored in the liver. Then, we searched for an other
site of fatty acid utilisation and energy wasting. In rats,
BAT is a well-known site for energy wastage due to the
Table 3: Lipids, protein and carbohydrate repartition from the standard, coconut and butter diet
week 3 16
standard coco butter standard coco butter
kcal/rat/day 45 64 62 73 178 95
% lipid 7 29 47 45 42
% SFA 0.8 26.6 32.0 41.3 28.0
% MUFA 2.2 1.8 13.0 2.8 12.0
% PUFA 4.0 0.6 2.0 0.9 2.0
% from control diet 4 2 3 3
% from high fat diet 25 45 42 39
%  p r o t e i n 1 6 1 41 3 1 31 3
% from control diet 10 6 6 6
% from high fat diet 4 7 7 7
% carbohydrate 77 57 40 42 45
% from control diet 48 25 27 31
% from high fat diet 9 15 15 14
Compounds are expressed in % of total energyNutrition & Metabolism 2007, 4:4 http://www.nutritionandmetabolism.com/content/4/1/4
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abundance of mitochondria and the profusion of an
uncoupling protein (UCP1) in these mitochondria. Inter-
scapular BAT depot was weighed and we estimated lipid
oxidation by HAD activity and quantified the UCP1 pro-
tein content in high fat diet and standard diet fed rats.
Intrascapular BAT depot was heavier (+23%) in coconut
diet fed animals (Fig. 6A) while there was only a non sig-
nificant trend in butter diet fed rat (+12%), possibly due
to both little variations and a small number of rats in this
group. A greater mitochondrial HAD activity was observed
in coconut diet fed rats as compared with standard rats
but not in butter fed rats (+55%; P < 0.05). A higher UCP1
protein content was observed in mitochondria from both
coconut and butter diet fed rat (in arbitrary unit: coconut:
+25%, butter: +28%; P < 0.05). Taken together, these
results suggest a thermogenic activation of BAT that may
result in fat oxidation contributing to the maintenance of
body weight and the protection of liver.
Discussion
In rodents, we succeeded in increasing lipid and caloric
intake by a very large amount with an ad libitum access to
diet. Nevertheless, this nutritional manipulation did not
reproduce the typical hepatic lesion of NASH, i.e. steato-
sis, inflammation and fibrosis. No accumulation of tria-
cylglycerols was observed in the liver of rats fed coconut
oil containing 90% of SFA or butter with 51% of SFA.
Such ability to overcome excessive energy intake may be
related to rat ability to dissipate excess energy as heat. It is
particularly true for young rats that resist becoming obese
when fed a cafeteria-diet by increasing energy expenditure
[33] through thermogenic processes occurring in liver
Estimated daily caloric intake (A and C) and body mass (B and D) in different diet groups over time Figure 1
Estimated daily caloric intake (A and C) and body mass (B and D) in different diet groups over time. Rats received either a 
standard diet (white triangles), a coconut diet (black circles), a butter diet (grey circles) or a methionine-choline deficient diet 
(grey squares). Values are mean ± SEM from 4 to 10 animals per group, P < 0.05:   different from standard. ºNutrition & Metabolism 2007, 4:4 http://www.nutritionandmetabolism.com/content/4/1/4
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[34] and BAT [35]. Our results show that, in rats fed a high
fat diet, the ability of the liver to oxidize fatty acid, as
assessed by i) ketone body formation, and ii) hepatocyte
and mitochondrial respiration, is not enhanced. In our
model, the liver of Wistar rats appears very mildly affected
by an overload in lipid intake and we can assume that
fatty acid exportation from the liver is sufficient to favour
peripheral storage. High fat feeding probably induced an
increased capacity to export triacylglycerol in the form of
VLDL. Indeed it has been shown that feeding a diet with
20% hydrogenated coconut oil was shown to increase
VLDL and LDL levels by 15–17% in rats and by 44% in
mice. Furthermore plasma ApoE and ApoB were increased
while hepatic ApoE mRNA and ApoB mRNA were
unchanged [36]. Moreover, in our study, the high fat fed
rats had increased white adipose tissue mass, which is in
accordance with a higher triacylglycerol export from the
liver to the adipose tissue. Similarly, feeding rats with var-
ious high fat diets (coconut oil, olive oil, menhaden oil,
etc.) was shown to increase their epididymal fat mass [37-
39]. However, we noted that fat accumulation in white
adipose tissue was different depending on the type of fatty
acid in the diets, and more precisely the length of the car-
bon chain. Indeed, coconut oil rich in medium chain sat-
urated fat (mainly: lauric acid; C12:0; 44.6%) led to a
lower peripheral accumulation than butter diet rich in
longer chain saturated fat (mainly palmitic acid; C16:0;
21.7%). Many studies demonstrated that medium chain
triglycerides (MCTs), such as in coconut oil, cause signifi-
cant reduction in body weight or fat pad size in animals
and humans [40-42]. This reduction of fat pad could be
explained by the fact that MCT are transported directly to
the liver via the portal vein and thus do not pass the adi-
pose tissue before hepatic disposal. These characteristics
could be responsible for the different rates of MCT oxida-
tion versus LCT [43], and then could partly account for the
difference in fat accumulation observed in white adipose
tissue.
Another way to explain the lack of hepatic steatosis during
lipid overload is peripheral utilisation. Mammals possess
specialised thermogenic BAT that is characterized by a
high amount of mitochondria containing high levels of
UCP1, an uncoupling protein, located in the mitochon-
drial inner membrane [44]. UCP activation (by coldness
or diet) results in the uncoupling of substrate oxidation
from ADP phosphorylation [45], with a resultant increase
in heat production [44]. In that thermogenic process, fatty
acids act not solely as substrates for β-oxidation but are
also involved in the uncoupling process by activating
UCP1 transcription and activity [46]. UCP1 expression is
regulated by a fatty acid activated transcriptional factor:
peroxisome proliferator-activated receptor (PPAR) [47].
In our study interscapular BAT is larger, or tends to be
larger, in the high fat fed groups, concomitantly with and
increased content in UCP1, suggesting the implication of
this tissue in fatty acid oxidation. BAT thermogenesis and
UCP1 expression are known to increase during high-fat
feeding, possibly to dissipate energy and to regulate body
weight [35,47-49]. We can therefore postulate that rats
can adapt to excessive lipid ingestion: firstly, by increasing
the storage of fatty acids in peripheral white adipose tis-
sues, and secondly by over-expressing the UCP1-related
thermogenesis in BAT.
At this time, the reference model for the study of NASH is
the MCD diet [31,32]. We confirm here that such diet
induces a striking steatosis, demonstrated by a massive
increase in hepatic triacylglycerol content. In the MCD
diet-fed rats, steatohepatitis is the consequence of both
the high-fat content and the methionine and choline defi-
ciency. The lack of methionine reduces glutathione syn-
thesis and impairs antioxidant defences against radical
attacks. In addition, the choline deficiency impairs lipid
exportation by decreasing the phosphatidylcholine syn-
thesis, leading to a reduction in the fatty acid export from
the liver [50]. The fact that, after an MCD diet, the high
steatosis is associated with the blocking of the lipid export
from the liver consorts with our hypothesis that, in our
study, high-fat fed rats are resistant to liver injury thanks
to a very efficient lipid exportation. Apart from steatohep-
atitis, the key feature of human NASH, the MCD diet fails
to induce the other characteristics of NASH, i.e. abdomi-
Relative weight of retroperitoneal white adipose tissue  (WAT) in rats fed either a standard (Std), coconut (Coco),  butter (Butter) or methionine-choline deficient diet (MCD) Figure 2
Relative weight of retroperitoneal white adipose tissue 
(WAT) in rats fed either a standard (Std), coconut (Coco), 
butter (Butter) or methionine-choline deficient diet (MCD). 
Data are means ± SEM; n = 10 for standard, coco and MCD 
groups, and n = 4 for butter group.  P < 0.01 vs standard 
diet.
ºNutrition & Metabolism 2007, 4:4 http://www.nutritionandmetabolism.com/content/4/1/4
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nal obesity and increased calorie intake. Therefore, the
MCDD model is adequate to study the consequence of fat
accumulation and inflammation in hepatocytes but is
inadequate to study the pathogenesis of steatohepatitis.
In this work, to mimic the diet habits of NASH patients
[22], we realised a high fat diet with high level of medium
chain SFA (i.e., coconut oil or butter). However, in rats,
high fat diet with SFA (51% or 86%) was not efficient to
induce steatosis or steatohepatitis. The comparison
between the different high fat diet in Table 4[20,51-54],
showed that there was a large variation in fat quantity in
the regimens used in several studies. Surprisingly, it was
not the diet with the higher percentage of fat that induced
the most striking steatosis. The fattiest diets with 35–49%
of lipid (w/w) (our model and the Lieber's or Zou's diets
[20,53]) did not always induce steatosis or only a mild
one (two fold increase as compared to their control). By
contrast, a diet with "only" 10% of fat (w/w) developed
steatosis and inflammation [54]. There is considerable
evidence that the type and not the proportion of fat in a
diet is a key determinant of fat accumulation and lesions
in liver disease. Another interesting point was the percent-
age and the type of carbohydrates present in the diet.
Indeed, increased dietary supply of carbohydrate could
promote steatosis by increasing hepatic lipid uptake or de
novo synthesis. Many studies showed that high sucrose
supply induced obesity, insulino-resistance and steatosis
in rodents [11,55-58]. Diets that were enriched with com-
parable amount of glucose or glycerol did not produce
any over hepatic pathology. Surprisingly, in the studies
presented in Table 4, steatosis was not always correlated
Diameter and volume of isolated adipocytes from the retroperitoneal white adipose tissue of rats fed standard diet or coconut  diet Figure 3
Diameter and volume of isolated adipocytes from the retroperitoneal white adipose tissue of rats fed standard diet or coconut 
diet. Measures were realised in triplicate on 3 rats per group; values are means ± SEM,  P < 0.001 vs standard diet. ºNutrition & Metabolism 2007, 4:4 http://www.nutritionandmetabolism.com/content/4/1/4
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H&E and reticulin stained sections from rats fed standard diet (A), coconut diet (B), butter diet (C) for 14 weeks or MCD diet  (D) for 6 weeks (magnification × 10), lipid vesicles are shown by a black arrow and inflammation point by a white arrow Figure 4
H&E and reticulin stained sections from rats fed standard diet (A), coconut diet (B), butter diet (C) for 14 weeks or MCD diet 
(D) for 6 weeks (magnification × 10), lipid vesicles are shown by a black arrow and inflammation point by a white arrow. (E) 
Liver triacylglycerol content (mg/g liver) in standard diet (std), coconut diet (Coco), butter diet (Butter) or MCD diet 
(MCDD). Results are means ± SEM,  P < 0.05 vs standard. ºNutrition & Metabolism 2007, 4:4 http://www.nutritionandmetabolism.com/content/4/1/4
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Liver capacity to oxidize fatty acids was assessed by (A) ketone body production and (B) oxygen uptake Figure 5
Liver capacity to oxidize fatty acids was assessed by (A) ketone body production and (B) oxygen uptake. Hepatocytes were iso-
lated from 24 h starved Wistar rats. Cell viability was checked by a measure of (C) gluconeogenesis, in the presence of dihy-
droxyacetone and medium (octanoate) or long (oleate) chain fatty acids. (D) Rat liver mitochondria control state respiration 
was obtained with 5 Mm succinate/0.5 mM malate/1.25 μM rotenone as substrates. State 3 respirations were initiated with 1 
mM ADP. Each determination was performed in triplicate from at least ten preparations for the three different diets: standard 
diet (white), coconut diet (black), butter diet (hatched). Results are means ± SEM. No significant difference between diets was 
observed.Nutrition & Metabolism 2007, 4:4 http://www.nutritionandmetabolism.com/content/4/1/4
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(A) Relative interscapular brown adipose tissue (BAT) mass in rats fed either a standard diet (Std), coconut diet (Coco) or but- ter diet (Butter) Figure 6
(A) Relative interscapular brown adipose tissue (BAT) mass in rats fed either a standard diet (Std), coconut diet (Coco) or but-
ter diet (Butter). Data are means ± SEM; n = 10 for standard group, coco group, and n = 4 for butter group.   P < 0.05. (B) 
Western blot analysis of UCP1 content in brown adipose tissue from rat fed standard diet, coconut diet or butter diet. Detec-
tions were performed with 40 μg of BAT mitochondrial proteins. Negative control was liver from standard rats. (C) 3-
hydroxyacyl-CoA dehydrogenase (HAD) activity is measured spectrophotometrically and expressed in micromoles per minute 
per gram protein. Data are means ± SEM; n = 8 for standard group, coco group, and n = 4 for butter group.   P < 0.05.
º
ºNutrition & Metabolism 2007, 4:4 http://www.nutritionandmetabolism.com/content/4/1/4
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with the presence of sucrose in the diet [20,59]. More
studies are therefore needed to clarify the possible links
between lipids and carbohydrates in NASH pathogenesis.
The lipid composition of the different diets which induce
steatohepatitis (see Table 4) [19,20,51,52,54], were lard
and corn oil, both oils rich in unsaturated fatty acids. We
can observe that fat of all the diets inducing steatosis and
inflammation (Table 4) were richer in MUFA and PUFA
(>30% and >20% of total fat respectively) as compared to
our diet (5% and 2%). The injurious effect of unsaturated
fatty acids, and particularly n-6 polyunsaturated fatty
acids, was associated with enhanced lipid peroxidation
and decreased concentrations of antioxidant enzymes,
implicating oxidative stress as a causal factor. Indeed, dif-
ferent studies showed the pro-inflammatory effect of pol-
yunsaturated n-6 fatty acids which exacerbate liver
oxidative stress [60,61] and promote the development of
NASH.
During the two last century, in Western diets, there has
been a huge increase in n-6 fatty acid consumption and,
the ratio of n-6 over n-3 fatty acids has increased from 1:1
to 15–20:1 [61,62]. Arachidonic acid (n-6) and eicosap-
entanoic acid (n-3) are precursors for the production of
eicosanoids, and have opposite metabolic effects. Cardio-
vascular diseases, diabetes, obesity, cancer and other
pathologies are associated with increased production of
thromboxane A2, leukotriene B4, Il-1β, IL-6 and TNF. All
these factors increase consequently to a rise in n-6 fatty
acid intake and decrease with a higher n-3 fatty acid intake
[63]. Different studies showed the pro-inflammatory
effect of polyunsaturated n-6 fatty acids which exacerbate
liver oxidative stress [63,64] and promote the develop-
ment of NASH. It follows that the development of steato-
hepatitis with high fat diet in rats may be facilitated by the
use of MUFA and PUFA, especially n-6 fatty acid, than
SFA. However, these results contradict the observations
made in humans where the daily intake of PUFA is around
5% (w/w) in the general population and 3.5% in NASH
patients [22]. A high fat diet with saturated fatty acids is
not sufficient to induce a steatosis and then a steatohepa-
titis. A number of studies showed, that it may be more
suitable to use a high mono- and polyunsaturated fatty
acid diet to induce NASH in rats. It appears here that the
key factor could be the possible induction of the lipid per-
oxidation and pro-inflammatory cytokine production by
the high level of PUFA leading to steatosis and inflamma-
tion. Another possibility is that Wistar rat is not a suitable
model to study obesity and pathologic modifications in
the liver consecutively to a modification of the diet [65].
Conclusion
In conclusion, Wistar rats have an incredible capacity to
adapt to a large increase of lipids in their alimentation.
The mechanism underlying this resistance to high fat feed-
ing is complex and involves both a change in body com-
position, with an increased storage in white adipose
tissue, and an activation of lipid oxidation in BAT. We can
conclude that, feeding Wistar rats with a high saturated fat
diet does not induce liver failure and cannot be used as
model of NASH. However, it is a good model for studying
the adaptations of the organism to a high fat diet. Hence,
it is still necessary to conceive a diet that can induce
NASH, maybe by coupling a high fat diet with a stress, like
inducing insulino-resistance or increasing ROS produc-
tion.
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